Synapse - Alison Moskowitz

Results (360)

Veliparib (ABT-888), bendamustine, and rituximab (VBR) is well tolerated and efficacious in patients with lymphoma: Final analysis of a phase 1b clinical trial of VB and a cohort expansion of VBR in patients with B-cell lymphoma

Meeting Abstract

Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Younes, A.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; more...
Blood (2015)

Fulltext@MSK | Save

Long-term follow up of pediatric patients with Hodgkin lymphoma treated with high dose therapy and autologous stem cell transplantation

Meeting Abstract

Roth, L. G.; O'Donohue, T.; Trippett, T.; Klein, E.; Kernan, N. A.; Kobos, R.; Prockop, S.; Scaradavou, A.; Shukla, N.; Steinherz, P. G.; more...
Blood (2015)

Fulltext@MSK | Save

A prospective study of allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma

Meeting Abstract

Perales, M. A.; Cho, C.; Eaton, A.; Moskowitz, A. J.; Nguyen, V.; Gonzales-Dadiz, A. M. R.; Devlin, S.; Giralt, S. A.; Jakubowski, A. A.; Matasar, M. J.; more...
Blood (2015)

Fulltext@MSK | Save

Successful treatment of peripheral T-cell lymphoma with allogeneic stem cell transplantation: A large single-center experience

Meeting Abstract

Mehta-Shah, N.; Chou, J.; Maloy, M.; Zhang, Z. G.; Moskowitz, A. J.; Moskowitz, C. H.; Barker, J. N.; Giralt, S.; Perales, M. A.; Horwitz, S. M.; more...
Blood (2015)

Fulltext@MSK | Save

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration

Meeting Abstract

Cheah, C. Y.; Broeckelmann, P. J.; Moskowitz, A. J.; Engert, A.; Jerkeman, M.; El-Galaly, T. C.; Vose, J.; Villa, D.; Connors, J. M.; Feldman, T.; more...
Blood (2015)

Fulltext@MSK | Save

Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay

Meeting Abstract

Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
Blood (2015)

Fulltext@MSK | Save

Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

Meeting Abstract

Shah, G. L.; Bantilan, K. S.; Verwys, S. L.; McCall, S. J.; Yahalom, J.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.
Blood (2015)

Fulltext@MSK | Save

TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin

Meeting Abstract

Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
Blood (2015)

Fulltext@MSK | Save

Other new agents for Hodgkin lymphoma

Book Section

Moskowitz, A. J.; Younes, A.
In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

Fulltext@MSK | Save

A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma

Meeting Abstract

Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save